Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Chloro-3-ethylbenzaldehyde → 4-[8-(4-Chloro-3-ethylbenzyl)-2-oxo-1-oxa-3,8-diazaspiro[4.5]dec-3-yl]benzoic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Chloro-3-ethylbenzaldehyde | HCID 55265095 | — |
| 반응물 | 4-{2-Oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-ylbenzoic acid hydrochloride | HCID 66764696 | — |
| 생성물 | 4-[8-(4-Chloro-3-ethylbenzyl)-2-oxo-1-oxa-3,8-diazaspiro[4.5]dec-3-yl]benzoic acid | HCID 86685274 | 43.7% |
반응 단계
The title compound was prepared from 4-(2-oxo-1-oxa-3,8-diazaspiro[4.5]dec-3-yl)benzoic acid hydrochloride salt (20 mg, 0.064 mmol; Example 5-1, Step 4) and 4-chloro-3-ethylbenzaldehyde (11.86 mg, 0.070 mmol), following essentially the same procedure described in Example 7-1. The residue was purified by reverse phase (C-18) HPLC eluting with acetonitrile/water+0.1% NH3. The solvent was evaporated to provide the title compound as a white solid (12 mg).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08742110B2 |
| 출처 데이터셋 | uspto-grants-2014_06 |
| ORD ID | ord-2d755abae5d440d5b273911850973d66 |
| 출처 메모 | uspto-grants-2014_06 |